Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Systemic lupus erythematosus: a review
CH Siegel, LR Sammaritano - Jama, 2024 - jamanetwork.com
Importance Systemic lupus erythematosus (SLE) is a chronic autoimmune disease
characterized by inflammation and immune-mediated injury to multiple organ systems …
characterized by inflammation and immune-mediated injury to multiple organ systems …
[کتاب][B] Examining illiberal trends and anti-EU politics in east Central Europe from a domestic perspective: State of research and outline of the book
LH Anders, A Lorenz - 2021 - library.oapen.org
In East Central Europe (ECE), democracy and the rule of law are under siege, most notably
in Hungary and Poland and, to a lesser extent, also in the Czech Republic and Slovakia …
in Hungary and Poland and, to a lesser extent, also in the Czech Republic and Slovakia …
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study
Background: Patients with chronic inflammatory disease (CID) treated with
immunosuppressive medications have increased risk for severe COVID-19. Although mRNA …
immunosuppressive medications have increased risk for severe COVID-19. Although mRNA …
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
Objective Randomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed
to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a …
to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a …
Two-year, randomized, controlled trial of belimumab in lupus nephritis
Background In adults with active lupus nephritis, the efficacy and safety of intravenous
belimumab as compared with placebo, when added to standard therapy (mycophenolate …
belimumab as compared with placebo, when added to standard therapy (mycophenolate …
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Lupus nephritis: new progress in diagnosis and treatment
Systemic lupus erythematosus (SLE) is a chronic multifactorial autoimmune disease that
affects many organs, including the kidney. Lupus nephritis (LN) is a common manifestation …
affects many organs, including the kidney. Lupus nephritis (LN) is a common manifestation …
Novel paradigms in systemic lupus erythematosus
The heterogeneity of systemic lupus erythematosus (SLE), long recognised by clinicians, is
now challenging the entire lupus community, from geneticists to clinical investigators …
now challenging the entire lupus community, from geneticists to clinical investigators …
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
A Dima, C Jurcut, F Chasset… - Therapeutic …, 2022 - journals.sagepub.com
The antimalarial hydroxychloroquine (HCQ) has demonstrated several crucial properties for
the treatment of systemic lupus erythematosus (SLE). Herein, we reviewed the main HCQ …
the treatment of systemic lupus erythematosus (SLE). Herein, we reviewed the main HCQ …